# Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization

> **NCT07304102** · NA · NOT_YET_RECRUITING · sponsor: **W.L.Gore & Associates** · enrollment: 100 (estimated)

## Conditions studied

- Common Iliac Artery Aneurysm
- Aorto Iliac Aneurysm

## Interventions

- **DEVICE:** GORE® EXCLUDER® IBE Plus Stent Graft

## Key facts

- **NCT ID:** NCT07304102
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-03
- **Final completion:** 2032-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07304102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07304102, "Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07304102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*